181 related articles for article (PubMed ID: 28910695)
1. MDS classification is improving in an era of the WHO 2016 criteria of MDS: A population-based analysis among 9159 MDS patients diagnosed in the Netherlands.
Dinmohamed AG; Visser O; Posthuma EFM; Huijgens PC; Sonneveld P; van de Loosdrecht AA; Jongen-Lavrencic M
Cancer Epidemiol; 2017 Oct; 50(Pt A):137-140. PubMed ID: 28910695
[TBL] [Abstract][Full Text] [Related]
2. Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population-based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010.
Dinmohamed AG; Visser O; van Norden Y; Huijgens PC; Sonneveld P; van de Loosdrecht AA; Jongen-Lavrencic M
Eur J Cancer; 2014 Mar; 50(5):1004-12. PubMed ID: 24388662
[TBL] [Abstract][Full Text] [Related]
3. A comparative review of classification systems in myelodysplastic syndromes (MDS).
Bennett JM
Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011
[TBL] [Abstract][Full Text] [Related]
4. Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions.
Valent P; Horny HP
Eur J Clin Invest; 2009 Jul; 39(7):548-53. PubMed ID: 19453651
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of morphological classification models for myelodysplastic syndromes in an era of the revised International Prognostic Scoring System.
van Spronsen MF; Ossenkoppele GJ; Westers TM; van de Loosdrecht AA
Eur J Cancer; 2016 Mar; 56():10-20. PubMed ID: 26798967
[TBL] [Abstract][Full Text] [Related]
6. Current pathology practices in and barriers to MDS diagnosis.
Glauser TA; Sagatys EM; Williamson JC; Burton BS; Berger C; Merwin P; Sugrue M; Bennett JM
Leuk Res; 2013 Dec; 37(12):1656-61. PubMed ID: 24220584
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes.
Germing U; Aul C; Niemeyer CM; Haas R; Bennett JM
Ann Hematol; 2008 Sep; 87(9):691-9. PubMed ID: 18575866
[TBL] [Abstract][Full Text] [Related]
8. Hematopathological concepts and controversies in the diagnosis and classification of myelodysplastic syndromes.
Vardiman JW
Hematology Am Soc Hematol Educ Program; 2006; ():199-204. PubMed ID: 17124061
[TBL] [Abstract][Full Text] [Related]
9. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
[TBL] [Abstract][Full Text] [Related]
10. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.
Navarro I; Ruiz MA; Cabello A; Collado R; Ferrer R; Hueso J; Martinez J; Miguel A; Orero MT; Pérez P; Nolasco A; Carbonell F
Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393
[TBL] [Abstract][Full Text] [Related]
11. The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands.
Dinmohamed AG; van Norden Y; Visser O; Posthuma EF; Huijgens PC; Sonneveld P; van de Loosdrecht AA; Jongen-Lavrencic M
Leuk Res; 2015 Feb; 39(2):177-82. PubMed ID: 25533930
[TBL] [Abstract][Full Text] [Related]
12. [Scoring analysis on prognosis of 63 patients with melodysplastic syndrome].
Wei J; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):305-11. PubMed ID: 18426654
[TBL] [Abstract][Full Text] [Related]
13. Coding of specific subgroups of myelodysplastic syndromes in a population-based cancer registry: prospects for improvement.
Polednak AP; Phillips C
J Registry Manag; 2012; 39(3):107-14. PubMed ID: 23443454
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplastic syndromes: diagnosis and staging.
Malcovati L; Nimer SD
Cancer Control; 2008 Oct; 15 Suppl():4-13. PubMed ID: 18813205
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndromes classification and risk stratification.
Komrokji RS; Zhang L; Bennett JM
Hematol Oncol Clin North Am; 2010 Apr; 24(2):443-57. PubMed ID: 20359636
[TBL] [Abstract][Full Text] [Related]
16. The myelodysplastic syndromes: diagnosis, molecular biology and risk assessment.
Bennett JM; Komrokji RS
Hematology; 2005; 10 Suppl 1():258-69. PubMed ID: 16188686
[TBL] [Abstract][Full Text] [Related]
17. World Health Organization classification of myelodysplastic syndromes.
Czader M; Orazi A
Curr Pharm Des; 2012; 18(22):3149-62. PubMed ID: 22571693
[TBL] [Abstract][Full Text] [Related]
18. Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification.
Font P; Loscertales J; Benavente C; Bermejo A; Callejas M; Garcia-Alonso L; Garcia-Marcilla A; Gil S; Lopez-Rubio M; Martin E; Muñoz C; Ricard P; Soto C; Balsalobre P; Villegas A
Ann Hematol; 2013 Jan; 92(1):19-24. PubMed ID: 22948274
[TBL] [Abstract][Full Text] [Related]
19. [The application of a new prognostic score system for 435 cases of primary myelodysplastic syndrome diagnosed with WHO classification].
Wang XQ;
Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):633-7. PubMed ID: 19954053
[TBL] [Abstract][Full Text] [Related]
20. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
